ADDvise Group AB (publ) (ADDV-A.ST)
SEK 11.2
(1.36%)
SEK 11.2
(1.36%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 300.6 Million SEK | 91.22% |
| 2022 | 157.2 Million SEK | 261.0% |
| 2021 | 43.54 Million SEK | 27.12% |
| 2020 | 34.25 Million SEK | 83.89% |
| 2019 | 18.62 Million SEK | 73.0% |
| 2018 | 10.76 Million SEK | 41.03% |
| 2017 | 7.63 Million SEK | -46.36% |
| 2016 | 14.23 Million SEK | 4566.56% |
| 2015 | 305 Thousand SEK | -88.7% |
| 2014 | 2.7 Million SEK | 404.67% |
| 2013 | 535 Thousand SEK | 130.31% |
| 2012 | -1.76 Million SEK | -206.96% |
| 2011 | -575 Thousand SEK | 87.7% |
| 2010 | -4.67 Million SEK | 0.0% |
| 2009 | - SEK | 100.0% |
| 2008 | -464 Thousand SEK | -135.12% |
| 2007 | 1.32 Million SEK | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 64.2 Million SEK | -15.19% |
| 2024 Q2 | 57.8 Million SEK | -9.97% |
| 2024 Q3 | 66.4 Million SEK | 14.88% |
| 2023 Q2 | 86.5 Million SEK | 25.36% |
| 2023 Q3 | 66.6 Million SEK | -23.01% |
| 2023 FY | 300.6 Million SEK | 91.22% |
| 2023 Q4 | 75.7 Million SEK | 13.66% |
| 2023 Q1 | 69 Million SEK | -13.15% |
| 2022 FY | 157.2 Million SEK | 261.0% |
| 2022 Q1 | 16.45 Million SEK | 5.33% |
| 2022 Q2 | 28.49 Million SEK | 73.22% |
| 2022 Q3 | 32.8 Million SEK | 15.11% |
| 2022 Q4 | 79.44 Million SEK | 142.2% |
| 2021 FY | 43.54 Million SEK | 27.12% |
| 2021 Q1 | 6.02 Million SEK | -52.1% |
| 2021 Q2 | 12.35 Million SEK | 105.01% |
| 2021 Q3 | 9.55 Million SEK | -22.66% |
| 2021 Q4 | 15.62 Million SEK | 63.53% |
| 2020 FY | 34.25 Million SEK | 83.89% |
| 2020 Q2 | 12.35 Million SEK | 373.62% |
| 2020 Q1 | 2.6 Million SEK | -58.27% |
| 2020 Q4 | 12.57 Million SEK | 87.16% |
| 2020 Q3 | 6.72 Million SEK | -45.6% |
| 2019 Q3 | 3.55 Million SEK | -18.4% |
| 2019 FY | 18.62 Million SEK | 73.0% |
| 2019 Q1 | 4.47 Million SEK | -13.84% |
| 2019 Q2 | 4.35 Million SEK | -2.73% |
| 2019 Q4 | 6.24 Million SEK | 75.93% |
| 2018 Q2 | 2.64 Million SEK | -2.5% |
| 2018 Q4 | 5.19 Million SEK | 2397.12% |
| 2018 FY | 10.76 Million SEK | 41.03% |
| 2018 Q1 | 2.71 Million SEK | 1800.0% |
| 2018 Q3 | 208 Thousand SEK | -92.15% |
| 2017 Q2 | 4.44 Million SEK | 50.56% |
| 2017 FY | 7.63 Million SEK | -46.36% |
| 2017 Q4 | 143 Thousand SEK | 53.76% |
| 2017 Q3 | 93 Thousand SEK | -97.91% |
| 2017 Q1 | 2.95 Million SEK | -20.98% |
| 2016 FY | 14.23 Million SEK | 4566.56% |
| 2016 Q3 | 3.86 Million SEK | -57.85% |
| 2016 Q4 | 3.73 Million SEK | -3.36% |
| 2016 Q2 | 9.17 Million SEK | 460.37% |
| 2016 Q1 | -2.54 Million SEK | 35.82% |
| 2015 FY | 305 Thousand SEK | -88.7% |
| 2015 Q1 | 4.71 Million SEK | 805.99% |
| 2015 Q2 | 3.11 Million SEK | -34.05% |
| 2015 Q3 | -3.55 Million SEK | -214.24% |
| 2015 Q4 | -3.96 Million SEK | -11.65% |
| 2014 Q4 | -668 Thousand SEK | -14.58% |
| 2014 Q1 | 2.2 Million SEK | 129.39% |
| 2014 Q2 | 1.74 Million SEK | -21.14% |
| 2014 Q3 | -583 Thousand SEK | -133.47% |
| 2014 FY | 2.7 Million SEK | 404.67% |
| 2013 Q4 | 963 Thousand SEK | 1705.0% |
| 2013 FY | 535 Thousand SEK | 130.31% |
| 2013 Q1 | -1.32 Million SEK | -336.56% |
| 2013 Q2 | 952 Thousand SEK | 172.12% |
| 2013 Q3 | -60 Thousand SEK | -106.3% |
| 2012 Q3 | -1.35 Million SEK | -756.8% |
| 2012 Q1 | -1.17 Million SEK | -463.78% |
| 2012 Q2 | 206 Thousand SEK | 117.53% |
| 2012 Q4 | 558 Thousand SEK | 141.24% |
| 2012 FY | -1.76 Million SEK | -206.96% |
| 2011 FY | -575 Thousand SEK | 87.7% |
| 2011 Q3 | -140 Thousand SEK | -129.98% |
| 2011 Q4 | 323 Thousand SEK | 330.71% |
| 2011 Q1 | -1.22 Million SEK | -276.92% |
| 2011 Q2 | 467 Thousand SEK | 138.12% |
| 2010 FY | -4.67 Million SEK | 0.0% |
| 2010 Q4 | -325 Thousand SEK | 82.03% |
| 2010 Q3 | -1.8 Million SEK | -56.9% |
| 2010 Q2 | -1.15 Million SEK | 16.81% |
| 2010 Q1 | -1.38 Million SEK | 0.0% |
| 2009 Q4 | - SEK | 0.0% |
| 2009 FY | - SEK | 100.0% |
| 2009 Q2 | 256 Thousand SEK | 152.89% |
| 2009 Q1 | -484 Thousand SEK | -27.03% |
| 2009 Q3 | - SEK | -100.0% |
| 2008 FY | -464 Thousand SEK | -135.12% |
| 2008 Q1 | 491 Thousand SEK | 31.28% |
| 2008 Q2 | 69 Thousand SEK | -85.95% |
| 2008 Q4 | -381 Thousand SEK | 0.0% |
| 2007 Q4 | 374 Thousand SEK | 0.0% |
| 2007 FY | 1.32 Million SEK | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acarix AB (publ) | -77.55 Million SEK | 487.606% |
| ADDvise Group AB (publ) | 300.6 Million SEK | 0.0% |
| Arcoma AB | 4.66 Million SEK | -6350.644% |
| Bactiguard Holding AB (publ) | -131.93 Million SEK | 327.843% |
| BICO Group AB (publ) | -618.3 Million SEK | 148.617% |
| Boule Diagnostics AB (publ) | 39.27 Million SEK | -665.47% |
| CellaVision AB (publ) | 167.05 Million SEK | -79.945% |
| Clinical Laserthermia Systems AB (publ) | -65.93 Million SEK | 555.917% |
| Chordate Medical Holding AB (publ) | -29.57 Million SEK | 1116.517% |
| C-Rad AB (publ) | 44.24 Million SEK | -579.414% |
| Duearity AB (publ) | -25.76 Million SEK | 1266.79% |
| Dignitana AB (publ) | -15.02 Million SEK | 2100.532% |
| Episurf Medical AB (publ) | -94.8 Million SEK | 417.089% |
| Getinge AB (publ) | 3.81 Billion SEK | 92.119% |
| Scandinavian Real Heart AB (Publ) | -68.44 Million SEK | 539.179% |
| Iconovo AB (publ) | -45.77 Million SEK | 756.665% |
| Integrum AB (publ) | 6.51 Million SEK | -4515.852% |
| Luxbright AB (publ) | -25.8 Million SEK | 1264.916% |
| Mentice AB (publ) | -679 Thousand SEK | 44370.987% |
| OssDsign AB (publ) | -91.95 Million SEK | 426.895% |
| Paxman AB (publ) | 12.61 Million SEK | -2282.122% |
| Promimic AB (publ) | -9.11 Million SEK | 3396.776% |
| Qlife Holding AB (publ) | -168.69 Million SEK | 278.189% |
| SciBase Holding AB (publ) | -53.93 Million SEK | 657.296% |
| ScandiDos AB (publ) | -13.48 Million SEK | 2329.474% |
| Sectra AB (publ) | 518.49 Million SEK | 42.024% |
| Sedana Medical AB (publ) | -65.54 Million SEK | 558.602% |
| Senzime AB (publ) | -133.74 Million SEK | 324.756% |
| SpectraCure AB (publ) | -21.35 Million SEK | 1507.897% |
| Stille AB | 44.95 Million SEK | -568.713% |
| Vitrolife AB (publ) | -3.58 Billion SEK | 108.376% |
| Xvivo Perfusion AB (publ) | 38.5 Million SEK | -680.658% |